PA
TCBI icon

PharVision Advisers’s Texas Capital Bancshares TCBI Stock Holding History

PharVision Advisers’s Portfolio TCBI Stock Details TCBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,470
Closed -$378K – 994
2025
Q3 		$378K Buy
+4,470
New +$382K 0.21% 101

Other funds holding TCBI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

PharVision Advisers's TCBI Position: Q4 2025 in Review

PharVision Advisers sold out of Texas Capital Bancshares (TCBI) in Q4 2025, closing a stake of 4,470 shares — an estimated $378K sold.

PharVision Advisers first reported a position in TCBI in Q3 2025 and held it in 1 quarter. The position peaked at $378K in Q3 2025. 344 funds tracked by Wall St. Rank hold TCBI as of Q4 2025.

  • PharVision Advisers reported no remaining Texas Capital Bancshares position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 4,470 Texas Capital Bancshares shares in Q4 2025, an estimated $378K.
  • PharVision Advisers first reported a position in Texas Capital Bancshares in Q3 2025 and held it in 1 quarter.
  • PharVision Advisers's Texas Capital Bancshares position peaked at $378K in Q3 2025.
  • 344 funds tracked by Wall St. Rank held Texas Capital Bancshares as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.